Page 14 - INFORMATION FOR HEALTH CARE PROFESSIONALS
P. 14
Authorship and acknowledgements
Author: Hanan Abramovici Ph.D.
Co-authors: Sophie-Anne Lamour, Ph.D. and George Mammen, Ph.D.
Affiliations:
Cannabis Legalization and Regulation Branch, Health Canada, Ottawa, ON, Canada K1A 0K9
Email: hanan.abramovici@canada.ca
Acknowledgements:
Health Canada would like to acknowledge and thank the following individuals for their comments and suggestions with regard to
the content in this information document:
Donald I. Abrams, M.D.
Chief, Hematology-Oncology
San Francisco General Hospital
Integrative Oncology
UCSF Osher Center for Integrative Medicine
Professor of Clinical Medicine
University of California San Francisco
San Francisco, CA 94143-0874
USA
Pierre Beaulieu, M.D., Ph.D., F.R.C.A.
Full professor
Department of Pharmacology and Anesthesiology
Faculty of Medicine
University of Montreal
Office R-408, Roger-Gaudry Wing
P.O. Box 6128 – Downtown Branch
Montréal, Québec
H3C 3J7
Canada
Bruna Brands, Ph.D.
Full Professor
Department of Pharmacology and Toxicology
Program Director, Collaborative Program in Addiction Studies
University of Toronto
33 Russell Street
Toronto, ON
M5S 2S1
Canada
Ziva Cooper, Ph.D.
Assistant Professor of Clinical Neurobiology
Division on Substance Abuse
New York State Psychiatric Institute and Department of Psychiatry
College of Physicians and Surgeons Columbia University
1051 Riverside Drive
New York, NY 10032
USA
7
